Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kojiro Ohba

Showing results (41-50 of 131) with videos related to

Pageof 14
Sort By:
Asian Journal of Endoscopic Surgery|February 22, 2026
Robot-Assisted Radical Nephrectomy for Renal Cell Carcinoma in a Pelvic Kidney: Case ReportDaiki Kawashima, Kojiro Ohba, Masaharu Oki, et al.
In Vivo (Athens, Greece)|June 23, 2022
Effects of β3 Agonists and Anticholinergic Drugs on Defecation in Patients With Overactive BladderHidenori Ito, Tomohiro Matsuo, Hiroki Kurata, et al.
Virchows Archiv : an International Journal of Pathology|April 13, 2006
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tractYasuyoshi Miyata, Kojiro Ohba, Shigeru Kanda, et al.
The Journal of Urology|June 7, 2006
Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosisYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Anticancer Research|July 9, 2011
Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature reviewYasuyoshi Miyata, Yuji Sagara, Tomohiro Matsuo, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysisYasuyoshi Miyata, Koichiro Nomata, Kojiro Ohba, et al.
Oncology Letters|March 31, 2017
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancerYasuyoshi Miyata, Kensuke Mitsunari, Asai Akihiro, et al.
Urology|November 15, 2012
Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesisYasuyoshi Miyata, Kojiro Ohba, Tomohiro Matsuo, et al.
Plos One|March 22, 2013
High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancerYasuyoshi Miyata, Shin-ichi Watanabe, Yuji Sagara, et al.
Anticancer Research|March 8, 2011
Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinomaKojiro Ohba, Yasuyoshi Miyata, Shin-Ichi Watanabe, et al.
Pageof 14

Showing results (41-50 of 131) with videos related to

Sort By:
Pageof 14
Asian Journal of Endoscopic Surgery|February 22, 2026
Robot-Assisted Radical Nephrectomy for Renal Cell Carcinoma in a Pelvic Kidney: Case ReportDaiki Kawashima, Kojiro Ohba, Masaharu Oki, et al.
In Vivo (Athens, Greece)|June 23, 2022
Effects of β3 Agonists and Anticholinergic Drugs on Defecation in Patients With Overactive BladderHidenori Ito, Tomohiro Matsuo, Hiroki Kurata, et al.
Virchows Archiv : an International Journal of Pathology|April 13, 2006
Pathological function of prostaglandin E2 receptors in transitional cell carcinoma of the upper urinary tractYasuyoshi Miyata, Kojiro Ohba, Shigeru Kanda, et al.
The Journal of Urology|June 7, 2006
Tumor lymphangiogenesis in transitional cell carcinoma of the upper urinary tract: association with clinicopathological features and prognosisYasuyoshi Miyata, Shigeru Kanda, Kojiro Ohba, et al.
Anticancer Research|July 9, 2011
Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature reviewYasuyoshi Miyata, Yuji Sagara, Tomohiro Matsuo, et al.
Cancer Chemotherapy and Pharmacology|August 7, 2012
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysisYasuyoshi Miyata, Koichiro Nomata, Kojiro Ohba, et al.
Oncology Letters|March 31, 2017
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancerYasuyoshi Miyata, Kensuke Mitsunari, Asai Akihiro, et al.
Urology|November 15, 2012
Tumor-associated stromal cells expressing E-prostanoid 2 or 3 receptors in prostate cancer: correlation with tumor aggressiveness and outcome by angiogenesis and lymphangiogenesisYasuyoshi Miyata, Kojiro Ohba, Tomohiro Matsuo, et al.
Plos One|March 22, 2013
High expression of HuR in cytoplasm, but not nuclei, is associated with malignant aggressiveness and prognosis in bladder cancerYasuyoshi Miyata, Shin-ichi Watanabe, Yuji Sagara, et al.
Anticancer Research|March 8, 2011
Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinomaKojiro Ohba, Yasuyoshi Miyata, Shin-Ichi Watanabe, et al.
Pageof 14